Research Article
Decision Making about Risk of Infection by Young Adults with CF
Table 2
Participant demographics.
| No. | Age | Gender | FEV1% predicted | BMI | IV antibiotics | Pseudomonas status |
| 1 | 21 | Female | 50.70 | 21.67 | 2 | Intermittent PsA | 2 | 18 | Male | 78.66 | 22.29 | 0 | Intermittent PsA | 3 | 24 | Female | 97.20 | 20.12 | 0 | Intermittent PsA | 4 | 18 | Female | 63.00 | 21.75 | 0 | Non-PsA | 5 | 17 | Female | 68.11 | 23.13 | 4 | Chronic PsA | 6 | 23 | Female | 36.64 | 17.57 | 3 | Chronic PsA | 7 | 21 | Female | 33.86 | 21.88 | 7 | Chronic PsA | 8 | 24 | Male | 59.20 | 21.27 | 1 | Chronic PsA |
|
|
FEV1% predicted and BMI are averages for the previous year; IV antibiotics are number of episodes in previous year.
|